HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Nano-Biotechnology & Biomaterials

Nano-Biotechnology & Biomaterials

At the intersection of nanotechnology and life sciences, nano-biotechnology & biomaterials is pioneering innovations that are reshaping diagnostics, therapeutics, and tissue engineering. Nanoscale systems such as quantum dots, liposomes, and dendrimers are being designed for targeted drug delivery and molecular imaging. Meanwhile, smart biomaterials are engineered to respond to biological stimuli, facilitating controlled release and promoting tissue regeneration. These materials, often biocompatible and biodegradable, are crucial in designing scaffolds, implants, and biosensors with enhanced performance. Nano-Biotechnology & Biomaterials also plays a transformative role in cancer treatment, regenerative therapies, and point-of-care diagnostics. With continuous advancements in surface modification and nanofabrication techniques, this field continues to merge precision with functionality across diverse biomedical and industrial platforms.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a